Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Identification of the receptor subtype involved in the analgesic effect of neurotensin.

Dubuc I, Sarret P, Labbé-Jullié C, Botto JM, Honoré E, Bourdel E, Martinez J, Costentin J, Vincent JP, Kitabgi P, Mazella J.

J Neurosci. 1999 Jan 1;19(1):503-10.

2.

Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.

Mechanic JA, Sutton JE, Berson AE, Wu X, Kwan J, Schreiber R, Pang Z, Button DC.

Eur Neuropsychopharmacol. 2009 Jul;19(7):466-75. doi: 10.1016/j.euroneuro.2009.01.004. Epub 2009 Feb 14.

PMID:
19223157
3.

In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.

Labbé-Jullié C, Dubuc I, Brouard A, Doulut S, Bourdel E, Pelaprat D, Mazella J, Martinez J, Rostène W, Costentin J, et al.

J Pharmacol Exp Ther. 1994 Jan;268(1):328-36.

PMID:
8301574
4.

Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.

Brun P, Mastrotto C, Beggiao E, Stefani A, Barzon L, Sturniolo GC, Palù G, Castagliuolo I.

Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G621-9.

5.

Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive.

Buhler AV, Choi J, Proudfit HK, Gebhart GF.

Pain. 2005 Mar;114(1-2):285-94. Epub 2005 Jan 26.

PMID:
15733655
6.

Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.

Li JH, Sicard F, Salam MA, Baek M, LePrince J, Vaudry H, Kim K, Kwon HB, Seong JY.

J Mol Endocrinol. 2005 Jun;34(3):793-807.

PMID:
15956348
7.

Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.

Bredeloux P, Costentin J, Dubuc I.

Behav Brain Res. 2006 Dec 15;175(2):399-407. Epub 2006 Oct 30.

PMID:
17074405
8.
9.

Involvement of NTS2 receptors in stress-induced analgesia.

Lafrance M, Roussy G, Belleville K, Maeno H, Beaudet N, Wada K, Sarret P.

Neuroscience. 2010 Mar 17;166(2):639-52. doi: 10.1016/j.neuroscience.2009.12.042. Epub 2009 Dec 24.

PMID:
20035838
10.

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.

Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, Pecceu F, Labbé-Jullié C, Kitabgi P, Soubrié P, Le Fur G, Maffrand JP.

J Pharmacol Exp Ther. 1997 Feb;280(2):802-12.

PMID:
9023294
11.

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.

Pettibone DJ, Hess JF, Hey PJ, Jacobson MA, Leviten M, Lis EV, Mallorga PJ, Pascarella DM, Snyder MA, Williams JB, Zeng Z.

J Pharmacol Exp Ther. 2002 Jan;300(1):305-13.

PMID:
11752130
12.

Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders.

Ferraro L, Tomasini MC, Beggiato S, Guerrini R, Salvadori S, Fuxe K, Calzà L, Tanganelli S, Antonelli T.

Mini Rev Med Chem. 2009 Oct;9(12):1429-38. Review.

PMID:
19929816
13.

Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.

Bredeloux P, Cavelier F, Dubuc I, Vivet B, Costentin J, Martinez J.

J Med Chem. 2008 Mar 27;51(6):1610-6. doi: 10.1021/jm700925k. Epub 2008 Mar 6.

PMID:
18321036
14.

Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors.

Sarret P, Esdaile MJ, Perron A, Martinez J, Stroh T, Beaudet A.

J Neurosci. 2005 Sep 7;25(36):8188-96.

15.

Expression of neurotensin receptors in human corneal keratocytes.

Bourcier T, Rondeau N, Paquet S, Forgez P, Lombet A, Pouzaud F, Rostène W, Borderie V, Laroche L.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1765-71.

PMID:
12036977
16.

Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells.

Carraway RE, Hassan S, Cochrane DE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):93-107. Epub 2006 Jan 6.

PMID:
16406549
17.

Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.

Gendron L, Perron A, Payet MD, Gallo-Payet N, Sarret P, Beaudet A.

Mol Pharmacol. 2004 Dec;66(6):1421-30. Epub 2004 Sep 10.

PMID:
15361549
18.

Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.

Einsiedel J, Hübner H, Hervet M, Härterich S, Koschatzky S, Gmeiner P.

Bioorg Med Chem Lett. 2008 Mar 15;18(6):2013-8. doi: 10.1016/j.bmcl.2008.01.110. Epub 2008 Feb 2.

PMID:
18276136
19.

Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.

Mazella J, Botto JM, Guillemare E, Coppola T, Sarret P, Vincent JP.

J Neurosci. 1996 Sep 15;16(18):5613-20.

20.

Common quantitative trait loci for alcohol-related behaviors and central nervous system neurotensin measures: hypnotic and hypothermic effects.

Erwin VG, Markel PD, Johnson TE, Gehle VM, Jones BC.

J Pharmacol Exp Ther. 1997 Feb;280(2):911-8.

PMID:
9023306

Supplemental Content

Support Center